一种重新设计的药物干扰核酸,以抑制新冠病毒Nsp13的双重活动
Nathan Soper1, Isabelle Yardumian1, Eric Chen1,2
1Department of Chemistry, New York University, New York, New York 10003, United States.
ACS chemical biology
|July 9, 2024
概括
一种名为IOWH-032的新药有效抑制了SARS-CoV-2 Nsp13螺旋酶的活性. 这一发现提供了一个有前途的新抗病毒策略来对抗SARS-CoV-2及其变种.
科学领域:
- 病毒学 病毒学
- 药物发现 药物发现 药物发现
- 结构生物学 结构生物学
背景情况:
- 随着COVID-19的爆发,人们越来越需要新型抗病毒疗法.
- 严重急性呼吸道综合征冠状病毒2 (SARS-CoV-2) 非结构性蛋白13 (Nsp13) 是病毒复制的关键螺旋酶,也是尚未探索的治疗标.
- 开发病毒酶的小分子抑制剂是具有挑战性的,因为蛋白质的灵活性和识别连接体结合口袋.
研究的目的:
- 通过虚拟查,识别SARS-CoV-2 Nsp13螺旋酶的潜在配体.
- 描述已识别的化合物的抑制机制和选择性.
- 验证针对SARS-CoV-2的已识别的抑制剂的治疗潜力.
主要方法:
- 在药物库中进行虚拟选,以识别Nsp13配体.
- 生物化学试验测量ATPase和Heliase活动.
- 动力和结合测试,计算建模和突变分析.
- 针对微生物螺旋酶的选择性分析和针对SARS-CoV-2变种的测试.
主要成果:
- 一种离子通道抑制剂IOWH-032被确定为在低微分子度下,SARS-CoV-2 Nsp13化酶和ATPase活动的强有力的抑制剂.
- IOWH-032与RNA结合接口结合,取代核酸基质,但不取代ATP.
- 该化合物对其他微生物螺旋酶的冠状病毒Nsp13具有选择性,并保留了来自SARS-CoV-2变种的Nsp13的活性.
- 已经证明IOWH-032可以降低人体细胞中的SARS-CoV-2病毒载荷.
结论:
- IOWH-032是一种新的,选择性的SARS-CoV-2 Nsp13抑制剂,为抗病毒药物开发提供了新的途径.
- 这些发现为IOWH-032的抗病毒活性提供了机制基础,并支持其作为治疗剂的潜力.
- 这项研究为发现额外的强大的调节器,准病毒螺旋酶的发现铺平了道路.
相关概念视频
RNA Interference
26.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.0K
Eukaryotic Transcription Inhibitors
9.8K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
9.8K
Types of RNA
63.5K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
63.5K
siRNA - Small Interfering RNAs
16.7K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.7K
Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.8K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.8K


